Related Experiment Video
Updated: May 27, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Product and trial design considerations on the path towards a vaccine to combat opioid overdose
Asimenia Angelidou1,2,3, Jacob A Koster1, Amy C Sherman4,5
1Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Abstract:
Opioid overdose deaths are an evolving public health emergency in the United States. Recent advancements in drug conjugate vaccine design and adjuvantation technologies have re-ignited interest in the potential clinical utility of opioid vaccination. Here we present the concept of fentanyl vaccination as a complementary strategy for opioid overdose prevention with a focus on vaccine safety, efficacy, and considerations for vaccine development and testing in early phase human clinical trials.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Related Concept Videos
Clinical Trials: Overview
Preclinical Development: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Discovery: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners